CoChat

Subendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix.

Open access
Pillarisetti, S, Paka, L, Obunike, J C, Berglund, L, Goldberg, I J · 1997 · Journal of Clinical Investigation
Cited by 112

The DOI matches its Crossref record.

Abstract

Vessel wall subendothelial extracellular matrix, a dense mesh formed of collagens, fibronectin, laminin, and proteoglycans, has important roles in lipid and lipoprotein retention and cell adhesion.In atherosclerosis, vessel wall heparan sulfate proteoglycans (HSPG) are decreased and we therefore tested whether selective loss of HSPG affects lipoprotein retention.A matrix synthesized by aortic endothelial cells and a commercially available matrix (Matrigel; Becton Dickinson Inc., Rutherford, NJ) were used.Treatment of matrix with heparinase/heparitinase (1 U/ml each) increased LDL binding by ‫ف‬ 1.5-fold.Binding of lipoprotein (a) [Lp(a)] to both subendothelial matrix and Matrigel ® increased 2-10-fold when the HSPG were removed by heparinase treatment.Incubation of endothelial cells with oxidized LDL (OxLDL) or lysolecithin resulted in decreased matrix proteoglycans and increased Lp(a) retention by matrix.The effect of OxLDL or lysolecithin on endothelial PG was abolished in the presence of HDL.The decrease in matrix HSPG was associated with production of a heparanase-like activity by OxLDL-stimulated endothelial cells.To test whether removal of HSPG exposes fibronectin, a candidate Lp(a) binding protein in the matrix, antifibronectin antibodies were used.The increased Lp(a) binding after HSPG removal was inhibited 60% by antifibronectin antibodies.Similarly, the increased Lp(a) binding to matrix from OxLDLtreated endothelial cells was inhibited by antifibronectin antibodies.We hypothesize that atherogenic lipoproteins stimulate endothelial cell production of heparanase.This enzyme reduces HSPG which in turn promotes Lp(a) retention.( J. Clin.Invest.1997.100:867-874.)Key words: pro- teoglycans • arteriosclerosis • heparin • endothelial cells • oxidized LDL MethodsMaterials.L -lysophosphatidylcholine (lysolecithin) from bovine brain was from Sigma Chemical Co.(St.Louis, MO).L -[4,5-3 H]leucine (147 Ci/mmol) and [ 35 S]sulfate aqueous solutions were from Amersham Corp. (Arlington Heights, IL).Heparinase and heparitinase were purchased from either Sigma Chemical Co. or Seikagaku America Inc. (Bethesda, MD).Chondroitin ABC lyase was from Seikagaku America Inc. 1 U will form 0.1 mol of unsaturated uronic acid/h.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci119602

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 112

Metadata

Authors
Pillarisetti, S., Paka, L., Obunike, J. C., Berglund, L., & Goldberg, I. J.
Venue
Journal of Clinical Investigation
Published
1997-08-15
Volume
100
Issue
4
Pages
867-874
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2050385895
Cited by
112
References
0
FWCI
2.42
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Subendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix. https://app.cochat.ai/papers/10.1172/jci119602
The paper
Pillarisetti, S., Paka, L., Obunike, J. C., Berglund, L., & Goldberg, I. J. (1997). Subendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix. Journal of Clinical Investigation. https://doi.org/10.1172/jci119602

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.